Release Date: 05/09/11 17:05 Summary: Results, Appendix 4E, and Financial Statements - Update Price Sensitive: No Download Document 1.51MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%